PATENT CLAIM ANALYSIS

Application Number: 15966274
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
This invention is directed to the treatment of pain by inhibiting adaptor associated kinase 1 (AAK1). Numerous AAK1 inhibitors are disclosed.

Claim (Index 4):
The method of  claim 3 , wherein the peripheral neuropathy is diabetic neuropathy.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13785355', '14483898', '13785271', '15145435', '15763281']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7496688770251995
- 35 USC 102 Novelty (BERT): 0.5276612864817389
- Combined Prediction Score: 0.7274681179708534
- Mean Citation Score: 257.27237599999995
- Max Citation Score: 290.64163
- Similarity Product: 178.05424279232682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test